Novo Ventures

Novo Ventures is a life science venture capital investor that provides knowledge, network and capital to the companies it backs. It invests in both private and public firms from an open evergreen fund, a structure that lets it take a long-term view.

What Novo Ventures offers

• Biotech investment — mainly companies with late preclinical or clinical-stage compounds.
• Medtech and digital health investment — companies that already sell commercially.
• Board involvement — team members sit on the boards of directors of portfolio companies.
• Scientific and commercial expertise — access to its network and life science know-how.

Who it works with

Companies developing drugs, medical devices and diagnostics. The firm reports that it made 46 investments in 2021, and it cites gene editing as one example area in its portfolio.

Key facts

• Offices: Copenhagen, London, Singapore, San Francisco and Boston
• Structure: open evergreen fund
• Sectors: biotechnology, medical technology and digital health